NCT06452862Recruiting
Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease
the Value of Multimodal Magnetic Resonance Imaging in the Diagnosis and Treatment Monitoring of Diabetic Kidney Disease
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The goal of this study is to investigate the value of noninvasive evaluation of multimodal magnetic resonance imaging in diagnosis and treatment of diabetic kidney disease (DKD). We aim to explore the feasibility of multimodal magnetic resonance imaging in the staging diagnosis of DKD, and establish a non-invasive method for evaluating the progression of DKD disease by combining imaging and biochemical indicators. Multimodal magnetic resonance examinations will be performed on diabetic patients with different stages as well as regular follow-up during treatment, in order to investigate the relationship between imaging findings and pathophysiological changes of the kidneys.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 5 Jun 2024
- Start date
- 6 Jun 2024
- Primary completion date
- 6 Jun 2027
- Lead sponsor
- Shengjing Hospital
- Diseases
- Chronic kidney disease
- NCT number
- NCT06452862
What you commit to
- Study type: Observational
- Planned participants: 150
- From 6 Jun 2024 to the primary completion date, 6 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Malignant tumor, active infection, or life expectancy \<1 year
- MRE contraindications (metal implants, claustrophobia, severe arrhythmia) or poor image quality
- Other primary kidney diseases or systemic diseases affecting renal function
Lab values
- eGFR \<15 mL/min/1.73m² or receiving renal replacement therapy
Other
- Pregnancy or lactation
Who the study is looking for
- Clinically diagnosed diabetic kidney disease (DKD)
- Age 18-80 years
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shengjing Hospital Coordinator of this site? Confirm its status | Shenyang | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.